109 related articles for article (PubMed ID: 30810839)
41. Patient-derived organoids for personalized gallbladder cancer modelling and drug screening.
Yuan B; Zhao X; Wang X; Liu E; Liu C; Zong Y; Jiang Y; Hou M; Chen Y; Chen L; Zhang Y; Wang H; Fu J
Clin Transl Med; 2022 Jan; 12(1):e678. PubMed ID: 35075805
[TBL] [Abstract][Full Text] [Related]
42. Glycolysis Changes the Microenvironment and Therapeutic Response Under the Driver of Gene Mutation in Esophageal Adenocarcinoma.
Zhu L; Yang F; Li X; Li Q; Zhong C
Front Genet; 2021; 12():743133. PubMed ID: 34956314
[No Abstract] [Full Text] [Related]
43. Development of an Oxidative Phosphorylation-Related and Immune Microenvironment Prognostic Signature in Uterine Corpus Endometrial Carcinoma.
Liu J; Chen T; Yang M; Zhong Z; Ni S; Yang S; Shao F; Cai L; Bai J; Yu H
Front Cell Dev Biol; 2021; 9():753004. PubMed ID: 34901000
[No Abstract] [Full Text] [Related]
44. TCGA database analysis of the tumor mutation burden and its clinical significance in colon cancer.
Chen J; Apizi A; Wang L; Wu G; Zhu Z; Yao H; Chen G; Shi X; Shi B; Tai Q; Shen C; Zhou G; Wu L; He S
J Gastrointest Oncol; 2021 Oct; 12(5):2244-2259. PubMed ID: 34790389
[TBL] [Abstract][Full Text] [Related]
45. Differences in genetics and microenvironment of lung adenocarcinoma patients with or without TP53 mutation.
Zeng D; Hu Z; Yi Y; Valeria B; Shan G; Chen Z; Zhan C; Lin M; Lin Z; Wang Q
BMC Pulm Med; 2021 Oct; 21(1):316. PubMed ID: 34635074
[TBL] [Abstract][Full Text] [Related]
46. DNA Methylation Regulator-Meditated Modification Patterns Define the Distinct Tumor Microenvironment in Lung Adenocarcinoma.
Yuan D; Wei Z; Wang Y; Cheng F; Zeng Y; Yang L; Zhang S; Li J; Tang R
Front Oncol; 2021; 11():734873. PubMed ID: 34552879
[TBL] [Abstract][Full Text] [Related]
47. Establishment of an Endocytosis-Related Prognostic Signature for Patients With Low-Grade Glioma.
Wang D; Liu S; Wang G
Front Genet; 2021; 12():709666. PubMed ID: 34552618
[TBL] [Abstract][Full Text] [Related]
48. Establishment of a novel CNV-related prognostic signature predicting prognosis in patients with breast cancer.
Hu W; Li M; Zhang Q; Liu C; Wang X; Li J; Qiu S; Li L
J Ovarian Res; 2021 Aug; 14(1):103. PubMed ID: 34364397
[TBL] [Abstract][Full Text] [Related]
49. Significance of Tumor Mutation Burden Combined With Immune Infiltrates in the Progression and Prognosis of Advanced Gastric Cancer.
Guo X; Liang X; Wang Y; Cheng A; Zhang H; Qin C; Wang Z
Front Genet; 2021; 12():642608. PubMed ID: 34306002
[TBL] [Abstract][Full Text] [Related]
50. A Novel Immune-Related Seventeen-Gene Signature for Predicting Early Stage Lung Squamous Cell Carcinoma Prognosis.
Fan T; Lu Z; Liu Y; Wang L; Tian H; Zheng Y; Zheng B; Xue L; Tan F; Xue Q; Gao S; Li C; He J
Front Immunol; 2021; 12():665407. PubMed ID: 34177903
[TBL] [Abstract][Full Text] [Related]
51. Identification of Potential Driver Genes Based on Multi-Genomic Data in Cervical Cancer.
Xu Y; Luo H; Hu Q; Zhu H
Front Genet; 2021; 12():598304. PubMed ID: 33664766
[No Abstract] [Full Text] [Related]
52. Evaluating the Potential of T Cell Receptor Repertoires in Predicting the Prognosis of Resectable Non-Small Cell Lung Cancers.
Song Z; Chen X; Shi Y; Huang R; Wang W; Zhu K; Lin S; Wang M; Tian G; Yang J; Chen G
Mol Ther Methods Clin Dev; 2020 Sep; 18():73-83. PubMed ID: 32995352
[TBL] [Abstract][Full Text] [Related]
53. Identification of critical radioresistance genes in esophageal squamous cell carcinoma by whole-exome sequencing.
Chen Z; Yao N; Zhang S; Song Y; Shao Q; Gu H; Ma J; Chen B; Zhao H; Tian Y
Ann Transl Med; 2020 Aug; 8(16):998. PubMed ID: 32953798
[TBL] [Abstract][Full Text] [Related]
54. Analyzing and validating the prognostic value and mechanism of colon cancer immune microenvironment.
Wang X; Duanmu J; Fu X; Li T; Jiang Q
J Transl Med; 2020 Aug; 18(1):324. PubMed ID: 32859214
[TBL] [Abstract][Full Text] [Related]
55. Genome-wide identification of CpG island methylator phenotype related gene signature as a novel prognostic biomarker of gastric cancer.
Zeng Z; Xie D; Gong J
PeerJ; 2020; 8():e9624. PubMed ID: 32821544
[TBL] [Abstract][Full Text] [Related]
56. Multi-omics Data Analyses Construct TME and Identify the Immune-Related Prognosis Signatures in Human LUAD.
Zhang Y; Yang M; Ng DM; Haleem M; Yi T; Hu S; Zhu H; Zhao G; Liao Q
Mol Ther Nucleic Acids; 2020 Sep; 21():860-873. PubMed ID: 32805489
[TBL] [Abstract][Full Text] [Related]
57. The Expressions and Mechanisms of Sarcomeric Proteins in Cancers.
Yang X; Ren H; Guo X; Hu C; Fu J
Dis Markers; 2020; 2020():8885286. PubMed ID: 32670437
[TBL] [Abstract][Full Text] [Related]
58. Identification of the Mutational Landscape of Gynecological Malignancies.
Chava S; Gupta R
J Cancer; 2020; 11(16):4870-4883. PubMed ID: 32626534
[No Abstract] [Full Text] [Related]
59. Slow skeletal muscle troponin T, titin and myosin light chain 3 are candidate prognostic biomarkers for Ewing's sarcoma.
Deng Y; Xie Q; Zhang G; Li S; Wu Z; Ma Z; He X; Gao Y; Wang Y; Kang X; Wang J
Oncol Lett; 2019 Dec; 18(6):6431-6442. PubMed ID: 31807166
[TBL] [Abstract][Full Text] [Related]
60. Aggregate analysis based on TCGA: TTN missense mutation correlates with favorable prognosis in lung squamous cell carcinoma.
Cheng X; Yin H; Fu J; Chen C; An J; Guan J; Duan R; Li H; Shen H
J Cancer Res Clin Oncol; 2019 Apr; 145(4):1027-1035. PubMed ID: 30810839
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
